Ixico appoints Grant Nash as Chief Financial Officer

Writer, Stock Market Wire
Thursday, February 7, 2019 - 08:49

Data analytics company Ixico on Thursday appointed Grant Nash as Chief Financial Officer.

Mr Nash would take up the role on 29 April. He joined IXICO from the UK Biobank, a national and international health research data resource, where he had been Finance Director since 2014.

Whilst with the UK Biobank, Mr Nash was also responsible for the UK Biocentre, which provides biomedical sample processing and archiving logistics to large-scale research studies. He was involved in separate fundraisings to raise more than £140m for a variety of research and development projects.

Conor Woolfson, who had assumed the role of interim Head of Finance in December 2018, would continue to perform until Mr Nash take up the CFO role in April, at which time Mr Woolfson would then continue in his role of Group Financial Controller.

At 8:49am: (LON:IXI) IXICO plc share price was -3.5p at 31.5p


Related content

Ixico wins contracts with two biopharmaceutical companies to provide imaging services technology

Data analytics company Ixico signed contracts with two biopharmaceutical companies to provide its technology-enabled imaging services to support an early phase study in Huntington's Disease...

Wed, 24/04/2019 - 09:28


IXICO chosen as partner for new medical imaging & artificial intelligence centre

Data analytics company IXICO said Friday it had been been chosen as partner in the newly established London Medical Imaging & Artificial Intelligence Centre for...

Fri, 01/03/2019 - 09:45


Ixico CFO Susan Lowther resigns

Ixico said Tuesday that Susan Lowther had resigned from her position as Chief Financial Officer to pursue other business interests.

Until a successor is...

Tue, 11/12/2018 - 08:40


Ixico slashes losses as revenue swells to record

Data analytics company Ixico said Tuesday annual losses more than halved supported by strong revenue in its core imaging business.

For the year ended...

Tue, 04/12/2018 - 09:00


Ixico expands scope of current contract with biopharmaceutical company

Data science company Ixico said Thursday it had signed a further change order to a current contract with a biopharmaceutical company, increasing the total contract...

Thu, 30/08/2018 - 08:45